These elevated basal levels of serum IFN-γ and the activated phenotype of human T cells after hPBMC transfer but before mAb treatment might be related to the onset of GvHD, which is reported for humanized mouse models [41, 42]. The gene discussed is IFNG; the disease is graft versus host disease.